PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS… · 2017-01-04 · 1 PRODUCT DEVELOPMENT...

7
1 PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS: Will you Help Key Stakeholders January 3, 2017 Martin Sklar, President & CEO AblaCor Medical Corporation (O) 781-444-1970 (M) 781-248-6841 www.ablacor.com [email protected]

Transcript of PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS… · 2017-01-04 · 1 PRODUCT DEVELOPMENT...

Page 1: PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS… · 2017-01-04 · 1 PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS: Will you Help Key Stakeholders January 3,

1

PRODUCT DEVELOPMENT IN LIFE SCIENCE &

HIGH TECH STARTUPS:

Will you Help Key Stakeholders

January 3, 2017

Martin Sklar, President & CEO AblaCor Medical Corporation

(O) 781-444-1970 (M) 781-248-6841 www.ablacor.com

[email protected]

Page 2: PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS… · 2017-01-04 · 1 PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS: Will you Help Key Stakeholders January 3,

2

My Bio

•  Engineer, Manager, Business, Quality & Regulatory

•  number of successful medical products

•  Six startups – 2 sold, 1 cashed out

•  > $1 B revenue generated for employers and clients

•  Patents 13 issued and 7 pending

•  Co-Founder and first President of MDG

•  Co-founder of two Med-tech consulting companies

•  Co-founder of AblaCor Medical Corporation

Page 3: PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS… · 2017-01-04 · 1 PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS: Will you Help Key Stakeholders January 3,

3

Current Opportunity

Business Develop revolutionary products to transform ablation into a first-line Atrial Fibrillation (AF) treatment

Problem Globally: ≥ 30% of all AF ablations repeated/yr

Target Market Size Globally: $1.2B market with 300K ablations/yr

Patents 3 issued & 7 pending

Competitive Advantage reduces repeat procedures to ≤ 10%

Investment $1.5M to design, build & test CircumBlator™ System

Validation Electrophysiologists, Cardiologists, Analysts

Page 4: PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS… · 2017-01-04 · 1 PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS: Will you Help Key Stakeholders January 3,

4

P’s are Wild

• Problem

• Pervasive?

• Potential?

• Practical Solution

• Patentable

• Profitable?

• Plan

• Partnering

• Perseverance

Page 5: PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS… · 2017-01-04 · 1 PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS: Will you Help Key Stakeholders January 3,

5

What you need to consider - Business q  Unmet need

q  Who are the customers?

q  What is their pain? q  What are current solution(s)?

q  What will compel customers to change to your solution?

q  Focused Market Size

q  Innovative concept v  Features v  Benefits

q  Is it Protectable v  Patentable v  FTO

q  Reimbursement

q  Regulatory

q  Team

q  Development Plan v  Realistic v  Proof-of-concept v  Testing v  Risks

q  Financials

v  Cost to Commercialization v  Investor excitement

§  Exit §  ROI

q  Build for business, not a sale

q  Compelling story

Page 6: PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS… · 2017-01-04 · 1 PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS: Will you Help Key Stakeholders January 3,

6

What you need to consider - Personal q  What are your goals?

q  Are you driven? v  If so what drives you? v  Can you live it?

q  What are your needs?

q  Do you have a family? v  What are their needs?

q  What sacrifices are you & they willing to make?

q  What is your financial tolerance?

q  What will make you quit?

q  Do you know your strengths & weaknesses?

q  Have you formed & managed Teams? q  What kind of a manger are you? q  Have you developed a professional network? q  How does your experience prepare you for your opportunity?

q  Do you have past failures? successes?

Page 7: PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS… · 2017-01-04 · 1 PRODUCT DEVELOPMENT IN LIFE SCIENCE & HIGH TECH STARTUPS: Will you Help Key Stakeholders January 3,

7

AblaCor Medical Corporation

Thank You!

Martin Sklar, President & CEO AblaCor Medical Corporation

(O) 781-444-1970 (M) 781-248-6841 www.ablacor.com

[email protected]